Cytokinetics | CYTK - Ebit



金融业
股票价格
USD
资产
USD 1.27B
现金及等价物
USD 129.84M
销售成本
USD 160K
流动资产
USD 839.47M
流动负债
USD 199.19M
债务
USD 1.29B
EBIT
USD -181.23M
EBITDA
USD -169.32M
员工
498
EPS每股收益
USD -1.67
股本和储备
USD -826.57M
销售毛利
USD 19.2M
债务利息支出
USD 33.34M
利息收入
USD 11.02M
贷款资金
USD 247.21M
市值
USD 8.54B
净收入
USD -206.03M
营业费用
USD 200.58M
营业利润
USD -181.23M
普通股股本
USD 124.43M
税前利润
USD -206.03M
销售收入
USD 19.35M
销售和管理费用
USD 104.9M
股票
USD 154K
贸易债权人
USD 24.71M
应收帐款人
USD 6.83M


Ebit 更改 日
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Amgen USD 3.83B 130M 2026-03
Arca Biopharma USD -34.43M 326K 2025-12
Bayer EUR 3.53B 2.42B 2026-03
Biogen USD 514.3M 502.8M 2026-03
Brainstorm Cell Therapeutics USD -2.05M 526K 2025-09
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cytokinetics USD -181.23M 2.86M 2026-03
Eisai JPY -10.31B 30.35B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Exelixis USD 251.34M 15.43M 2026-03
Geron USD -236K 10.55M 2026-03
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
Ligand Pharmaceuticals USD 60.33M 1.76M 2026-03
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.18B 118M 2026-03
Pfizer USD 4.99B 340M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03